In this issue of Interventional Cardiology Clinics, guest editor Dr. Nadia Sutton brings her considerable expertise to the topic of Cardiovascular Procedures in Women. Top experts in the field discuss the clinical approach to angina in women; revascularization strategies in women: do women benefit as much as men?; acute coronary syndrome management in women; dual antiplatelet and anticoagulation regimens for women undergoing percutaneous coronary intervention; and much more. - Contains 14 relevant, practice-oriented topics including strategies to improve the clinical outcomes of women with cardiogenic shock; considerations in the care of transgender and gender diverse patients requiring cardiac catheterization; considerations for women with congenital heart disease undergoing percutaneous cardiovascular procedures; and more. - Provides in-depth clinical reviews on cardiovascular procedures in women, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In this issue of Interventional Cardiology Clinics, guest editor Dr. Nadia Sutton brings her considerable expertise to the topic of Cardiovascular Procedures in Women. Top experts in the field discuss the clinical approach to angina in women; revascularization strategies in women: do women benefit as much as men?; acute coronary syndrome management in women; dual antiplatelet and anticoagulation regimens for women undergoing percutaneous coronary intervention; and much more. Contains 14 relevant, practice-oriented topics including strategies to improve the clinical outcomes of women with cardiogenic shock; considerations in the care of transgender and gender diverse patients requiring cardiac catheterization; considerations for women with congenital heart disease undergoing percutaneous cardiovascular procedures; and more. Provides in-depth clinical reviews on cardiovascular procedures in women, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Heart disease is the leading cause of death among US women over the age of 65, resulting in more deaths than all forms of cancer combined. Women are less likely to survive heart attacks than are men, possibly because symptoms in women may differ and may be less recognizable. In addition, women consistently tend to have worse clinical outcomes in percutaneous coronary interventions than do men. For these reasons, an issue on percutaneous interventions in women is timely.

In this issue of Interventional Cardiology Clinics, guest editors Drs. Frank F. Ing and Howaida El-Said bring their considerable expertise to the topic of Interventions for Congenital Heart Disease. Top experts in the field PDA occlusion in premature infants; the use of 3D imaging for pre-procedural planning for CHD interventions; PDA stents for pulmonary/systemic flow; venous rehabilitation in CHD; the use of flow restrictors in CHD; and much more. - Contains 14 relevant, practice-oriented topics including hybrid procedures in CHD; ACHD innovations; fetal Interventions; occlusion of the sinus venosus ASD; pulmonary artery stenting; lymphatic interventions in CHD; and more. - Provides in-depth clinical reviews on interventions for congenital heart disease, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In this issue of Interventional Cardiology Clinics, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions. Top experts in the field discuss regulation of platelet activation and coagulation; genetic determinants of P2Y12 inhibitors and clinical implications; switching P2Y12 receptor inhibiting therapies; high bleeding risk in patients undergoing coronary and structural heart interventions; and much more. - Contains 13 relevant, practice-oriented topics including antithrombotic therapy in atrial fibrillation patients undergoing coronary stenting; antithrombotic therapy in patients undergoing transcatheter aortic valve replacement; antithrombotic therapy in patients undergoing peripheral artery interventions; antiplatelet therapy in women; and more. - Provides in-depth clinical reviews on antiplatelet and anticoagulation therapy in cardiovascular and pulmonary embolism transcatheter interventions, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In ST segment elevation myocardial infarction (STEMI), the coronary artery is completely blocked by a blood clot. It is the most serious type of heart attack. The best treatment for STEMI patients is to have the blocked artery opened by balloon inflation within 90 minutes of arriving at a hospital. The 90-minute window is called "door-to-balloon time. The shorter the door-to-balloon time, the greater the chance of survival. Treatment of this life-threatening illness is reviewed in this issue.

Chronic total occlusion is the complete blockage of a coronary artery. Opening up such blocked passageways is one of the most difficult challenges for coronary interventionists. The procedures take longer than most interventional procedures and frequently have complications. Articles in this issue review the state of the art in percutaneous treatment of chronic total occlusion.